Normoglycaemia after transplantation of freshly isolated and cryopreserved pancreatic islets in Type 1 (insulin-dependent) diabetes mellitus
Purified islets of Langerhans and a kidney were transplanted into a 36-year-old patient who suffeded from renal failure secondary to a 25 year history of Type 1 (insulin-dependent) diabetes mellitus. The islet graft contained 243 000 fresh islets (mean islet diameter 150 μm) that were syngeneic with the kidney fraft and 368 000 cryopreserved islets that had been collected from four other donors. The total of 10 000 islets/kg body weight was infused into the liver via the umbilical vein. Immunosupperession was induced with antilymphocyte globulin and maintained with prednisone, cyclosporine and azathioprine. Serum C-peptide levels (ng/ml) during fasting and after standard mixed metal feeding (Sustacal) were <0.12 preoperatively. Postoperatively, insulin secretion was restored: fasting C-peptide rose during the first 4 weeks to levels of 4 to 5 and Sustacal elicited a further rise to 6 to 7. Transplant renal function was stable. Dialy fasting glucose (mmol/l, mean±SD) was 5.6±1 and 5.3±0.6 during the first and second months respectively and post-Sustacal glucose was 5.7+-0.8. Exogenous insulin therapy was progressively withdrawn and stopped duting the ninth week. Thereafter, fasting glucose was 4.7+-0.5, 24 h mean glucose was 6.6+-0.5, and normoglycaemia was maintained after Sustacal. These data show that this mass of freshly isolated and cryopreserved islets from multiple donors provided sustained function (3 months) that reversed insulin-dependence in an immunosuppressed Type 1 diabetic patient treated with simultaneous islet-kedney transplantation.
Key wordsPancreatic islet transplantation cryopreservation Type 1 (insulin-dependent) diabetes tissue bank
Unable to display preview. Download preview PDF.
- 1.Warnock GL, Ellis D, Rajotte RV, Dawidson I, Baekkeskov S, Egebjerg J (1988) Studies of the isolation and viability of human islets for Langerhans. Transplantation 45: 957–963Google Scholar
- 2.Gray DWR, McShane P, Grant A, Morris PJ (1984) A method for isolation of islets of Langerhans from the human pancreas. Diabetes 33: 1055–1061Google Scholar
- 3.Warnock GL, Cattral MS, Rajotte RV (1988) Normoglycemia after implantation of purified islets of Langerhans in dogs. Can J Surg 31: 421–426Google Scholar
- 4.Warnock GL, Kneteman NM, Ryan EA, Evans MG, Seelis REA, Halloran PF, Rabinovitch A, Rajotte RV (1989) Continued function of pancreatic islets after transplantation in type I diabetes. Lancet II: 570–572Google Scholar
- 5.Rajotte RV, Warnock GL, Coulombe MG (1988) Islet cryopreservation: methods and experimental results in rodents, large mammals and humans. In: van Schildgaarde R, Hardy MA (eds) Transplantation of the Endocrine Pancreas in Diabetes Mellitus. Elsevier science Publishers, Amsterdam, pp 125–135Google Scholar
- 6.McNary WF (1954) Zinc-dithizone reaction of pancreatic islets. J Histochem Cytochem 2: 185–194Google Scholar
- 7.Largiader F, Kolb E, Binswanger U (1980) A long-term functioning human pancreatic islet allotransplant. Transplantation 29: 76–77Google Scholar
- 8.Scharp DW, Lacy PE, Santiago JV et al. (1990) Insulin independence after islet transplantion into type I diabetic patient. Diabetes 39: 515–518Google Scholar
- 9.Diem P, Abid M, Radmon JB, Sutherland DER, Robertson RP (1990) Systemic venous drainage of pancreas allografts as independent cause of hyperinsulinemia in type I diabetic recipients. Diabetes 39: 534–539Google Scholar
- 10.Sandler S, Jansson L (1987) Blood flow measurements in autotransplanted pancreatic islets of the rat: impairment of the blood perfusion of the graft during hyperglycemia. J Clin Invest 80: 17–21Google Scholar